Zacks Small-Cap Research coverage specifically looks to focus on small- and micro-cap companies that are under-followed or under-valued by Wall Street. Our analysts seek to indentify and report on these companies, bringing to investors a unique opportunity to invest in small-cap ideas believed to be well-positioned for future growth. Our goal is to produce high quality research for the small cap portfolio. Grant Zeng: Grant has 8 plus years professional experience in equity research and analysis. He is currently a senior biotech analyst with Zacks Investment Research Inc. since March 2006. Before joining Zacks, Grant worked for TheStreet.com as a biotech analyst from 2005-2006. From Sept 2001 to December 2003, Grant worked for China Pacific Insurance Co. as an equity/fund analyst. Grant was a healthcare equity analyst with Young & Partners, LLC from Aug 2000 to September 2001. Grant had also teaching and researching experience in pharmaceutical science. Grant obtained his MBA with a major in Finance in 2000 from McMaster University, Canada. He also holds a Master of Science in Biochemistry from the University of Western Ontario, Canada; Master of Pharmacology and Bachelor of Medicine from Second Military Medical University, China. Grant is a Chartered Financial Analyst (CFA) charter holder, and series 7, 86/87 licensed. Ken Nagy: Ken has been a Senior Research Analyst in the Technology Sector at Zacks Investment Research since he first joined the firm in 2003. Ken’s prior analyst positions include Scudder Funds, Investor’s Bank and Trust, and Westrock Advisors. Mr. Nagy has been quoted in such publications as Forbes, Bloomberg, Reuters, CNN Money and Yahoo Finance. Ken’s education includes a Masters degree in Finance from Northeastern University, and a Bachelor of Arts in Accounting from Assumption College. He holds the Chartered Financial Analyst (CFA) designation and is a member of the Boston Security Analysts Society and the CFA Institute.
Nisha Hirani, M.D. is an experienced healthcare professional who serves as the Chief Scientific Advisor for Berg Capital Markets, LLC. In addition to her advisory role at Berg Capital Markets, LLC, Dr. Hirani currently works as a medical/healthcare industry consultant for NavMed Partners LLC. As a consultant, Dr. Hirani prepares proprietary client focused services including due diligence, valuation analysis, market research, and product research for biotechnology, pharmaceutical, healthcare staffing, healthcare IT and medical device companies, and is also a contributing writer for platforms such as Seeking Alpha and StockViews. Previously, Dr. Hirani worked as a biotechnology equity research analyst producing institutional quality equity research for under-valued and under-followed healthcare, biotechnology and medical device companies. Dr. Hirani’s initiating coverage reports, research reports and articles have been featured on both institutional and retail platforms including Thomson Reuters First Call, Bloomberg, Wall Street Source, Yahoo! Finance, Fidelity.com, and Google Finance. In the past, Dr. Hirani has taught embryology, performed research in the area of optical mammography, and taught English as a Second Language (ESL) classes. Dr. Hirani graduated from Tufts University with a B.S. in Biomedical Engineering and B.S in Biology, and received her Doctor of Medicine (M.D.) degree from St. George’s University School of Medicine. She completed her clinical clerkships primarily through the Barnabas Health System located in the New York Metropolitan area. In her free time, Dr. Hirani enjoys tennis, canvas painting, and volunteering for various non-profit organizations.